Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

7 has achieved the British Standards Institute (BSI) surveillance audit certification following a recent SOC II Type I compliance certification LONDON, Jan. 29, 2025 /PRNewswire/ -- Image Analysis ...

"Having such comprehensive quality compliance allows IAG to partner with companies seeking effective imaging biomarkers to support safety and efficacy of their drug candidates in clinical trials ...

As the company progresses through clinical trials and approaches potential regulatory milestones, a comprehensive analysis of its stock reveals both opportunities and challenges in the evolving ...

As the company progresses through clinical trials and approaches potential regulatory milestones, a comprehensive analysis of its stock reveals both opportunities and challenges in the evolving ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...